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Objectives: To determine whether Telemedicine intervention can 
affect hospital mortality, length of stay, and direct costs for pro-
gressive care unit patients.
Design: Retrospective observational.
Setting: Large healthcare system in Florida.
Patients: Adult patients admitted to progressive care unit (PCU) 
as their primary admission between December 2011 and August 
2016 (n = 16,091).
Interventions: Progressive care unit patients with telemedicine inter-
vention (telemedicine PCU [TPCU]; n = 8091) and without tele-
medicine control (nontelemedicine PCU [NTPCU]; n = 8000) were 
compared concurrently during study period.
Measurements and Main Results: Primary outcome was progres-
sive care unit and hospital mortality. Secondary outcomes were 
hospital length of stay, progressive care unit length of stay, and 
mean direct costs. The mean age NTPCU and TPCU patients 
were 63.4 years (95% CI, 62.9–63.8 yr) and 71.1 years (95% CI, 
70.7–71.4 yr), respectively. All Patient Refined-Diagnosis Related 
Group Disease Severity (p < 0.0001) and All Patient Refined-
Diagnosis Related Group patient Risk of Mortality (p < 0.0001) 
scores were significantly higher among TPCU versus NTPCU. 
After adjusting for age, sex, race, disease severity, risk of mortal-
ity, hospital entity, and organ systems, TPCU survival benefit was 
20%. Mean progressive care unit length of stay was lower among 
TPCU compared with NTPCU (2.6 vs 3.2 d; p < 0.0001). Post-
progressive care unit hospital length of stay was longer for TPCU 
patients, compared with NTPCU (7.3 vs 6.8 d; p < 0.0001). The 
overall mean direct cost was higher for TPCU ($13,180), com-
pared with NTPCU ($12,301; p < 0.0001).
Conclusions: Although there are many studies about the effects of 
telemedicine in ICU, currently there are no studies on the effects of 
telemedicine in progressive care unit settings. Our study showed 
that TPCU intervention significantly decreased mortality in pro-
gressive care unit and hospital and progressive care unit length of 
stay despite the fact patients in TPCU were older and had higher 
disease severity, and risk of mortality. Increased postprogres-
sive care unit hospital length of stay and total mean direct costs 
inclusive of telemedicine costs coincided with improved survival 
rates. Telemedicine intervention decreased overall mortality and 
length of stay within progressive care units without substantial 
cost incurrences. (Crit Care Med 2018; XX:00–00)
Key Words: direct costs; hospital mortality; length of stay; 
progressive care unit; telemedicine
Patients admitted to hospitals have different disease sever-ity and require different levels of care (1). A large pro-portion of low risk patients are admitted to ICUs just for 
monitoring purposes, thus increasing patient load and affect-
ing functionality of ICUs (2). Similarly, a significant proportion 
of patients who require more intensive care are treated in the 
wards (3, 4). There is an increasing need for step-down units 
such as progressive care units (PCUs) due to diverse population 
characteristics, increased proportion of aging patient popula-
tion, increasing cost of care, and shortage of intensivists (5). 
PCUs manage patients who need “intermediate” level of care—
patients who require more extensive care than in general wards, 
but less than in ICUs (6). PCUs were created to provide cost-
effective and high-standard care without negatively impacting 
patient outcomes for less severely ill patients who are admit-
ted to ICUs for monitoring or more serious patients who are 
treated in the wards (2, 7).
To overcome increasing patient demands and shortage of 
intensivists, telemedicine, a relatively new method of care deliv-
ery, has been applied to critical care (8, 9). Approximately, 11% DOI: 10.1097/CCM.0000000000002994
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of critical care units in the United States have integrated tele-
medicine and many have reported positive health outcomes (10). 
Telemedicine includes managing patients through monitoring 
devices controlled by physicians and nurses in remote locations. 
Telemedicine has improved patient outcomes through advanced 
monitoring, cognitive affordances, clinical decision-support 
functions, execution of life saving, and evidence-based critical 
care protocols. In a retrospective study that looked for the effect 
of telemedicine on mortality and length of stay (LOS) in com-
munity hospital ICUs, it was observed that telemedicine signifi-
cantly decreased odds of ICU mortality (odds ratio, 0.46; 95% 
CI, 0.32–0.66) when compared with pretelemedicine imple-
mentation stages (11). In addition, telemedicine also decreased 
LOS. Similarly, another study by Lilly et al (10) reported that 
hospital mortality rate significantly decreased from 13.6% before 
telemedicine implementation to 11.8% after intervention. ICU 
mortality also significantly reduced from 10.7% to 8.6% after the 
implementation. In a review article on acceptance of telemedi-
cine coverage among ICU staff, it was observed that telemedi-
cine in ICU (Tele-ICU) installations were rapidly accepted by 
ICU staff despite initial difficulties in autonomy, training, scru-
tiny, and malfunctions, primarily due to perceived benefits for 
patients among the ICU staff (12). Telemedicine coverage was 
associated with decreased ICU mortality and LOS as reported 
in a meta-analysis (13). Although many studies report improved 
patient quality and outcomes due to telemedicine (10, 11, 13–
15), some studies have noted mixed and inconsistent benefits 
and stark variations in the application of telemedicine (16–21). 
Intricacy and variability in the application of telemedicine, along 
with differences in study designs, creates a challenge to determine 
the impact on quality and return on investment (22–25).
Although previous studies have reported challenges, advan-
tages, and disadvantages of telemedicine implementation 
(9, 15, 22, 26–31), there are no studies exploring effect of these 
innovations on patient outcomes in PCUs. The main objec-
tive was to examine effects of telemedicine in PCU (TPCU) 
on hospital mortality, LOS, and direct costs among PCU 
patients using a retrospective observational study design at a 
large healthcare system. Results from our study could provide 
insights into association between telemedicine and patient 
outcomes.
METHODS
Study Design and Population
This study was reviewed and approved by the institutional 
review board. We performed a retrospective observational 
study, with primary data collected from patients admitted 
to PCUs between December 2011 and August 2016 across 
five hospitals in South Florida region. Not all PCU beds 
were equipped to receive telemedicine care; hence, patients 
who did not receive telemedicine (nontelemedicine PCU 
[NTPCU]) became suitable concurrent controls to those 
patients who received telemedicine (TPCU) in same unit or 
hospital. Hospital policies for those patients admitted or dis-
charged to PCUs were based on American College of Critical 
Care Medicine guidelines (3). Inclusion criteria were all adult 
patients admitted in PCUs as their primary admission with-
out a prior ICU admission. All patients required a minimum 
of 24 hours of PCU LOS to be included. If the encounter did 
not reach these thresholds, patients were excluded. When 
patients were downgraded to telemetry or med/surgical unit, 
they were consequently discharged from TPCU, regardless of 
bed availability. Patients were also excluded if demographics 
information was missing (Fig. 1).
Measures
Demographic variables included age, gender, and race/ethnic-
ity. Measures included admission diagnosis, PCU and hospital 
LOS, PCU and hospital mortality, and the “total direct cost” of 
hospitalization. Total direct cost is comprised of “direct fixed” 
and “direct variable.” Direct fixed costs are for unit level opera-
tions, and the cost of telemedicine is reflected in direct fixed 
costs per licensed bed per patient stay; “direct variable” includes 
variable clinician staffing and patient care utilization costs.
We used the All Patient Refined-Diagnosis Related Group 
(APR-DRG) disease severity and APR-DRG risk of mortality 
(ROM) to stratify patients based on severity scores. Both APR-
DRG disease severity and APR-DRG ROM were categorized 
into Minor (= 1), Moderate (= 2), Major (= 3), and Extreme 
(= 4) (32). Hospital mortality was defined as death in hospi-
tal due to any cause. Hospital LOS was calculated as difference 
between admission date and time and discharge date and time. 
PCU LOS was calculated from the time acuity status order was 
placed for each primary PCU stay until their status change 
was placed. Age was categorized into 18–40, 41–65, 66–85, and 
greater than and equal to 86 years. Race and ethnicity were cat-
egorized into White, Black, White Hispanic, Black Hispanic, 
and Other. Mortality (PCU and hospital), LOS (PCU and hos-
pital), and mean total direct costs were outcome measures.
Statistical Analyses
We used univariate, bivariate, chi-square, and independent 
samples t test to describe the demographic characteristics, APR-
DRG disease severity, and APR-DRG ROM. Bivariate statistics 
were also calculated for LOS and hospital mortality stratified by 
Figure 1. Inclusion of patients into telemedicine progressive care unit 
(PCU) (TPCU) and nontelemedicine PCU (NTPCU) groups.
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TPCU and NTPCU status. Survival analyses using a multivari-
ate Cox proportional hazards model were conducted to calculate 
hazard ratios (HRs) for hospital mortality. HR were adjusted for 
hospital entity, demographics, organ systems, APR-DRG disease 
severity, and APR-DRG ROM. Sensitivity analysis was performed 
after randomly selecting 50% TPCU patients (n = 4,000) and 
matching (1:1) these with NTPCU patients based on propensity 
score. Propensity score was calculated from a logistic regression 
model which included age, sex, race, APR-DRG disease severity, 
and APR-DRG ROM. Up to 95% (or n = 3,800) TPCU patients 
were matched 1:1 with the pool of control patients based on 
their closest propensity score. In addition to propensity score 
matching, HRs were calculated from this subsample after adjust-
ing for hospital entities and Agency for Healthcare Research and 
Quality clinical classification system (CCS) organ system catego-
ries in the model. Generalized linear mixed models were used 
for estimating differences in direct costs between two groups. 
For power and sample size calculation, it was hypothesized that 
after 15 days of admission into PCU, at least 5% difference in HR 
would be observed between two groups. A sample size of 7,993 
in each group would be required to detect the difference at 90% 
power and 5% level of significance. SAS software version 9.4 
(SAS Institute Inc., Cary, NC) was used for statistical analyses. 
Statistical significance was set at p value of less than 0.05.
RESULTS
Patient Characteristics
During the study period, 19,530 patients were admitted in the 
PCUs (2011–2016). After excluding patients who did not meet 
the study criteria, 16,091 patients were included in the study, 
8,091 (50.3%) patients admitted to TPCU, and 8,000 (49.7%) 
into NTPCU. The mean age of the participants admitted to 
NTPCU and TPCU was 63.4 years (95% CI, 62.9–63.8 yr) 
and 71.1 years (95% CI, 70.7–71.4 yr), respectively ( Table 1). 
Among patients admitted to TPCU, 50.6% were females, 
63.5% were Hispanics, 25.7% Whites, and 7.1% Blacks. Among 
those admitted to NTPCUs, 53.5% were females and 57.9% 
were Hispanics, 27.6% Whites, and 10.5% Blacks. APR Dis-
ease Severity (p < 0.0001) and APR patient ROM (p < 0.0001) 
scores were significantly different between patients admitted to 
TPCU and NTPCU.
Mortality and LOS
During the study period, 60 patients (0.7%) died in TPCU, 
compared with 83 patients (1%) in NTPCU (Table 1). The dif-
ference in proportion of patients who died in the TPCUs, com-
pared with NTPCUs, was statistically significant (p = 0.048). 
Hospital mortality rates were 4.4% for TPCUs and 5.2% for 
NTPCUs, and the differences were statistically significant 
(p = 0.013). Mean PCU LOS was higher among NTPCU 
patients compared with TPCU (3.2 vs 2.6 d; p < 0.0001). Post-
PCU hospital LOS was longer for TPCU patients, compared 
with NTPCU patients (7.3 vs 6.8 d; p < 0.0001). Unadjusted 
Cox proportion survival analysis showed that patients admit-
ted to TPCUs were 21% more likely to survive compared with 
those admitted to NTPCUs (Fig. 2). After adjusting for age, 
sex, race, APR-DRG disease severity, APR-DRG ROM, hospi-
tal entities, and organ systems, the survival benefit decreased 
slightly to 20% (Table 2). Within each Clinical Classifications 
Software (CCS) for International Classification of Diseases, 9th 
Edition and International Classification of Diseases, 10th Edi-
tion categories, patients with diseases and disorders of the kid-
ney and urinary tract (n = 679; HR, 0.40; 95% CI, 0.17–0.90; 
p = 0.028), nervous system (n = 1435; HR, 0.50; 95% CI, 
0.27–0.91; p = 0.023), and circulatory system (n = 4,601; HR, 
0.69; 95% CI, 0.50–0.95; p = 0.021) showed the highest survival 
benefit. Among five entities, highest survival benefit of 30% 
was seen at the facility which was an urban community full 
services hospital that were predominantly patients with cardio-
vascular and neurovascular illnesses in PCU. Sensitivity analysis 
was performed on a pool of 7,600 propensity score matched 
patients (3,800 in each group). Results from the sensitivity anal-
ysis showed that after accounting for age, sex, race, APR-DRG 
disease severity, APR-DRG ROM, hospital entities, and organ 
systems, patients in TPCU group were 44% (24–59%) more 
likely to survive compared with NTPCU patients.
Cost of Telemedicine in PCUs
The overall mean direct costs were higher for patients admit-
ted to TPCUs, compared with NTPCUs ($13,180 vs $12,301; 
p < 0.0001) (Table 3). Mean direct costs were higher for TPCUs 
in the age groups, 18–40, 41–65, and 66–85 years (p < 0.0001), 
but among greater than and equal to 86 years age group, it was 
higher for NTPCU group. TPCU patients with APR-DRG dis-
ease severity scores of major (p < 0.001) and extreme (p < 0.01) 
had significantly higher mean direct costs than patients did in 
NTPCU. Similarly, mean direct costs for patients with APR-
DRG ROM scores of major (p < 0.01) and extreme (p < 0.01) 
were significantly higher in patents admitted to TPCU when 
compared with NTPCUs. Patients with nervous, respiratory, 
and musculoskeletal system disorders, and diagnosis of preg-
nancy and childbirth in TPCU had higher mean direct costs; 
and in NTPCU group, it was higher among patients with endo-
crine and metabolic disorders.
DISCUSSION
Although there are many studies about the effects of Tele-ICU, 
currently, to the best of our knowledge, this is the first study 
to examine the impact of telemedicine on mortality, LOS, and 
direct costs in patients with PCU (TPCU) admissions. The ICU 
admission, discharge, and triage guidelines set forth by Nates 
et al (3) and endorsed by the Society of Critical Care Medi-
cine recommend patients with high severity of illness, multiple 
comorbidities, and need for organ support be cared for in a 
“step-down unit.” These types of units are variably referred to 
as “high dependency, intermediate, or transitional care units.” 
The label PCU has been applied to encompass all the variations. 
Just as varied as the labels are the configurations and capa-
bilities across healthcare settings. Little formal investigation 
exists to describe and evaluate the effectiveness of PCUs (3). 
It is hypothesized that ICU services, bed utilization, and patient 
Armaignac et al
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care outcomes may be positively impacted through use of 
PCUs (4, 33–35); similarly Tele-ICU has shown to impact these 
factors positively (10, 11, 13–15, 36) and therefore, Tele-PCU 
may also provide a distinct advantage. We found that PCU and 
hospital mortality rates were significantly lower for patients in 
TPCU group, compared with patients in NTPCUs. PCU LOS 
was also significantly lower for TPCU patients, compared with 
NTPCU patients. We found that mean post-PCU hospital LOS 
and total mean direct cost were higher for patients admitted to 
TPCUs that coincided with improved survival.
Several reasons PCUs were established or became part 
of the hospital system are because studies indicated that a 
TABLE 1. Characteristics of Telemedicine Progressive Care Unit and Nontelemedicine 
Progressive Care Unit Patients (n = 16,091)
Characteristics
Nontelemedicine  
Progressive Care Unit 
(n = 8,000)
Telemedicine  
Progressive Care 
Unit (n = 8,091) p
Age (yr), mean (95% CI) 63.4 (62.9–63.8) 71.1 (70.7–71.4) < 0.0001
Age groups, n (%)    
 18–40 964 (12.3) 441 (5.5) < 0.0001
 41–65 2,437 (31.2) 2,000 (24.7)  
 66–85 3,392 (43.4) 4,033 (49.8)  
 ≥ 86 1,018 (13.0) 1,617 (10.0)  
Gender, n (%)    
 Male 3,724 (46.5) 4,000 (49.4) < 0.001
 Female 4,276 (53.5) 4,091 (50.6)  
Race, n (%)    
 White 2,206 (27.6) 2,077 (25.7) < 0.0001
 Black 843 (10.5) 577 (7.1)  
 White Hispanic 4,541 (56.8) 5,060 (62.5)  
 Black Hispanic 87 (1.1) 75 (1.0)  
 Other 323 (4.0) 301 (3.7)  
APR-DRG severity of illness, n (%)    
 Minor = 1 1,214 (15.2) 671 (8.3) < 0.0001
 Moderate = 2 2,145 (26.9) 2,243 (27.8)  
 Major = 3 3,123 (39.1) 3,615 (44.7)  
 Extreme = 4 1,502 (18.8) 1,548 (19.2)  
APR-DRG risk of mortality, n (%)    
 Minor = 1 2,401 (30.1) 1,408 (17.4) < 0.0001
 Moderate = 2 1,786 (22.3) 2,154 (26.7)  
 Major = 3 2,419 (30.3) 2,980 (36.9)  
 Extreme = 4 1,378 (17.3) 1,535 (19.0)  
Deaths, n (%)    
 PCU 83 (1.0) 60 (0.7) 0.048
 Hospital 410 (5.2) 342 (4.4) 0.013
Length of stay, mean (95% CI)    
 PCU 3.2 (3.1–3.3) 2.6 (2.5–2.7) < 0.0001
 Hospital 6.8 (6.6–6.9) 7.3 (7.2–7.5) < 0.0001
APR-DRG = All Patient Refined-Diagnosis Related Group, PCU = progressive care unit.
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significant proportion of adult ICU occupancies were lower 
severity patients admitted for monitoring rather than active 
treatment (37). Often these patients were admitted postop-
eratively for observation and had very small mortality rates of 
0.03 with short ICU and hospital LOS (2). Solberg et al (38) 
concluded that the introduction of PCU has increased the 
operational efficiency of the ICU with fewer low risk patients 
being admitted. A recent prospective multinational European 
study demonstrated that adults admitted to ICUs of hospitals 
with an intermediate care unit (IMCU) have significantly lower 
adjusted hospital mortality 0.63 (95% CI, 0.45–0.88; p = 0.007) 
than those admitted to ICUs of hospitals without an IMCU 
after severity and characteristics adjustments (39). Closures of 
PCUs also seemed to have a negative impact on the ICUs (39). 
However, further evidence is required to cement the view that 
PCUs lead to improved patient outcomes and optimal health-
care delivery (6, 40).
Similar to our findings, previous studies conducted in 
ICU settings have shown that Tele-ICU was associated with 
improved patient outcomes. For example, in a prospective 
stepped-wedge clinical practice study, installation of Tele-
ICU was associated with decreased mortality and hospital 
LOS (10). This was attributed to improved adherence to best 
practices in critical care such as prevention of venous throm-
bosis, cardiovascular complications, ventilator associated 
pneumonia, stress ulcers, timely administration of anti-
microbial medications, and resuscitation procedures (10). 
Improvements in clinical outcomes due to Tele-ICU imple-
mentation in ICUs were also observed in a large scale study 
involving more than 24,000 patients (41). This study demon-
strated a decrease in severity-adjusted ICU LOS, along with 
a decrease of 0.77 in relative risk of hospital mortality (41). 
Probable mechanisms for this improvement include greater 
levels of participation of the Tele-ICU team in implementing 
patient care and improved coordination with bedside care-
givers (41). In another study, it was observed that severity-
adjusted ICU LOS significantly improved from 0.84 to –0.03 
(or 4,772 saved ICU days; p < 0.001) and severity-adjusted 
hospital LOS improved from 0.97 to –0.64 (or 6,091 saved 
floor days; p = 0.001) (42). In a study evaluating 15 rural mul-
tistate ICUs, Tele-ICU implementation was associated with 
lower mortality and LOS in ICUs (21). A meta-analysis of 
13 studies involving 35 ICUs showed similar findings where 
Tele-ICU implementation was associated with lower ICU 
mortality rates and LOS; there was no effect of Tele-ICU out-
side of ICU on hospital mortality rates or hospital LOS (13).
While implementing TPCUs, both costs and patient out-
come characteristics should be considered. Previous studies 
in this field revealed considerable variability concerning the 
benefits to mortality or LOS after Tele-ICU implementation 
in relationship to cost (43, 44). For example, an observational 
study of 4,142 ICU patients reported 24% increase in daily 
hospital costs, 43% increase in cost per case, and 28% increase 
in cost per patient (44). A retrospective study using adminis-
trative database from 106 adult ICU beds showed that capi-
tal costs for telemedicine units were $1,186,220 and annual 
operational costs were $1,250,112, thus accounting to $23,150 
per telemedicine unit (43). Benefits to mortality or LOS after 
Tele-ICU implementation may be associated with increased 
cost; however, it has also been noted the initial costs in estab-
lishing and operating TPCUs may be reclaimed over the years 
through cost savings due to favorable patient outcomes (23, 
24, 45, 46). The conduct of Tele-ICU cost analyses has been 
recognized as an “imperfect science,” (47) requires “alterna-
tive research designs,” (48) and is an “analyses of a complex 
intervention.” (24)
For our study, the total enterprise-wide annual operation 
cost for telemedicine was equally distributed across the orga-
nization as a cost per licensed bed per patient unit stay. This 
Figure 2. Survival curves for Cox proportional hazards model with 
telemedicine at progressive care unit (PCU) (TPCU) admission (solid 
line) and without telemedicine at PCU (NTPCU) admission (dotted line). 
LOS = length of stay.
TABLE 2. Cox Proportional Survival Analysis With Unadjusted and Adjusted Hazard Ratios 
for Hospital Mortality in Telemedicine Progressive Care Unit (n = 16,091)
Survival Analysis Unadjusted 
Adjusted
Model 1b Model 2c Model 3d
Hazard ratios (95% CI)a 0.79 (0.68–0.91) 0.71 (0.61–0.82) 0.80 (0.67–0.96) 0.56 (0.41–0.76)
a Reference: progressive care unit patients without telemedicine.
b Model 1: age, sex, and race.
c Model 2: age, sex, and race, All Patient Refined-Diagnosis Related Group (APR-DRG) severity of illness, APR-DRG risk of mortality, hospital entity, and organ 
systems.
d Model 3: propensity score matched on age, sex, and race, APR-DRG severity of illness, APR-DRG risk of mortality (n = 7,600).
Armaignac et al
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TABLE 3. Mean (95% CI) Direct Costs Associated With Patient Admissions Stratified by 
Telemedicine Progressive Care Unit and Nontelemedicine Progressive Care Unit  
(in U.S. Dollars; n = 16,091)
Category Characteristics
Nontelemedicine  
Progressive Care Unit
Telemedicine  
Progressive Care Unit p
Overall  12,301 (12,100–12,501) 13,180 (12,941–13,420) < 0.0001
Age groups 18–40 11,685 (11,093–12,277) 12,329 (11,219–13,439) 0.3
41–65 13,181 (12,785–13,577) 13,479 (12,985–13,973) 0.35
66–85 13,162 (12,832–13,492) 14,122 (13,776–14,467) < 0.0001
≥ 86 11,792 (11,265–12,318) 12,540 (12,062–13,017) 0.04
Gender Male 13,041 (12,702–13,379) 14,010 (13,652–14,369) < 0.0001
Female 12,334 (12,069–12,599) 13,098 (12,779–13,416) < 0.001
Race White 13,121 (12,723–13,519) 13,992 (13,522–14,462) < 0.005
Black 11,974 (11,267–12,681) 15,080 (14,072–16,089) < 0.0001
White Hispanic 12,548 (12,271–12,824) 13,220 (12,920–13,519) < 0.01
Black Hispanic 9,915 (8,378–11,452) 13,864 (11,725–16,002) < 0.003
Other 13,695 (12,524–14,866) 13,016 (11,754–14,278) 0.44
APR severity  
of illness
Minor = 1 10,039 (9,730–10,347) 9,818 (9,182–10,455) 0.54
Moderate = 2 10,380 (10,631–10,698) 10,666 (10,298–11,035) 0.25
Major = 3 12,319 (12,010–12,627) 13,138 (12,826–13,450) < 0.001
Extreme = 4 18,760 (18,082–19,438) 20,303 (19,585–21,020) < 0.01
APR risk  
of mortality
Minor = 1 10,247 (10,002–10,492) 10,493 (10,039–10,947) 0.35
Moderate = 2 11,872 (11,442–12,302) 11,583 (11,207–11,959) 0.32
Major = 3 12,997 (12,622–13,371) 13,718 (13,344–14,093) < 0.01
Extreme = 4 17,313 (16,612–18,013) 18,783 (18,070–19,495) < 0.004
Primary  admission 
diagnosis 
 classified by  
organ system
Circulatory system 12,980 (12,464–13,495) 13,301 (12,876–13,725) 0.35
Nervous system 10,649 (9,832–11,466) 12,378 (11,792–12,965) < 0.001
Respiratory system 11,334 (10,962–11,706) 12,707 (12,119–13,296) < 0.0001
Gastrointestinal system 13,446 (12,893–13,999) 12,808 (12,159–13,458) 0.14
Infectious diseases 14,309 (13,515–15,103) 15,001 (14,139–15,864) 0.24
Musculoskeletal system 16,277 (15,398–17,156) 19,047 (18,102–19,991) < 0.001
Renal and urinary tract 11,516 (10,702–12,330) 12,335 (11,315–13,356) 0.21
Endocrine/metabolic 
disorders
10,935 (10,644–11,227) 9,179 (7,862–10,496) < 0.0001
Blood disorders 17,482 (15,759–19,204) 16,130 (14,000–18,260) 0.34
Pregnancy and childbirth 9,306 (8,402–10,210) 12,255 (10,273–14,236) 0.0025
Injuries, toxins, and poisonings 9,395 (6,821–11,968) 9,293 (6,639–11,947) 0.95
Ear, nose, mouth, and throat 8,385 (6,442–10,328) 8,377 (6,417–10,338) 0.99
Alcohol and drug use 5,224 (4,140–6,309) 6,215 (4,353–8,076) 0.4
Male reproductive system 9,831 (8,749–10,913) 12,036 (7,077–16,994) 0.38
Mental disorders 7,672 (3,859–11,484) 6,839 (2,818–10,860) 0.73
Progressive care  
unit LOS (d)
< 2 10,441 (10,171–10,711) 11,276 (10,976–11,576) < 0.0001
≥ 2 14,600 (14,293–14,907) 15,986 (15,622–16,349) < 0.0001
Hospital LOS (d) < 5 8,357 (8,161–8,552) 8,057 (7,818–8,296) < 0.06
≥ 5 16,322 (16,006–16,638) 17,035 (16,709–17,361) < 0.002
APR = All Patient Refined, LOS = length of stay.
Boldface font indicates significance p value.
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cost was reflected in the “direct fixed” within the “total direct 
costs.” Because we wished to ascertain the exact added cost of 
telemedicine, inclusion of the “direct fixed” within the “total 
direct costs” was necessary. This turned out to be an advantage 
as we have accounted for both “direct variable” (direct patient 
care utilization) and “direct fixed” (cost of TPCU and cost of 
PCU level care). We believe inclusion of PCU level operational 
costs may be considered relevant for examination of the overall 
cost of care delivery. PCU cost of care delivery is fundamentally 
lower than that of ICU and higher than telemetry or med/surg. 
The cost of TPCU added to PCU is another layer of additional 
costs. However, our study demonstrated, despite the additional 
cost of TPCU, the total mean direct costs in the TPCU group 
only increased by a nominal amount of 300 dollars per patient 
per day when the estimated TPCU cost was $650 per patient 
per unit stay more than NTPCU in this healthcare system.
Yoo et al (25) compared Tele-ICU to non-Tele-ICU cost 
effectiveness through probabilistic analyses conducted on 
available literature to calculate incremental cost effectiveness 
ratios and quality-adjusted life years over a 5-year span. Yoo 
et al (25) calculated weighted averages from studies report-
ing both favorable and unfavorable costs/benefit ratios. Their 
resultant comparison for with and without tele models was 
comprised of the product of cost(s) multiplied by reported 
benefits available in literature to create impact ratios (0.94; 
0.71–1.14) for ICU and (1.02; 0.80–1.30) for floor post-ICU 
for alive patients (25). Combining the mean estimated costs for 
ICU and post-ICU plus tele-operational costs, the difference 
between total hospital cost with Tele-ICU and without was 
only 304 dollars per patient per hospital stay. To the extent that 
Yoo et al (25) data provide valid results as they are constructed 
upon the extant literature beleaguered with inherent variabil-
ity and theoretical assumptions, our results based on primary 
data are in agreement with the direction of their hypothetical 
results.
Our study has some limitations. The current study was con-
ducted on retrospective data and had limitations of an obser-
vational study design. The lack of ability to control for clinician 
selection of telemedicine intervention in PCU or the lack of 
technologically equipped bed availability in some locations is 
inherent in this study. The PCU bed configuration is complex 
in this health system and likely complex in other organizations 
based on available literature (3). Our system is mixture of beds 
and/or units with TPCU and NTPCU; therefore, selection 
bias may be of concern. Although each entity had both TPCU 
monitored and NTPCU beds under various configurations, all 
other services provided and staffing were considered relatively 
equal within entity and units. Additionally, majority of our 
patients were of Hispanic ethnicity, which is not representative 
of the general population.
The main strengths of our study were large sample size, rig-
orous analytical procedures, severity adjustments, and homog-
enous TPCU and NTPCU patient characteristics. Despite 
older and more severely ill patient population in TPCU group, 
we found statistically significant benefits. The circumstances of 
this study that not all PCU beds or units were equipped with 
TPCU capability, which created a suitable concurrent control 
group and propensity score matched analysis, may have mini-
mized this selection bias. In addition to this, pooling data from 
five different hospitals allowed us to minimize selection bias. 
Furthermore, there were equal distribution of deaths among 
the PCU sites based on their bed capacity. Although the use 
of TPCU versus NTPCU was driven by both availability and 
clinical judgment, PCU designation is based on acuity and was 
severity adjusted in this study. PCU is not only a relevant strat-
egy to reduce ICU LOS and readmissions and optimize ICU 
bed utilization, it serves the needs of many patients that do not 
require ICU level care but are at a high risk of deterioration. 
Tele-ICU innovation has improved ICU treatment in criti-
cal care, have reduced ICU mortality and ICU LOS based on 
numerous studies. Using these evidences, we can theorize on 
the efficiency and role in reducing morbidity and mortality in 
the PCU if a TPCU intervention approach is used.
CONCLUSIONS
Although there are many studies about the effects of telemedi-
cine in ICU, currently there are no studies on the effects of 
telemedicine in PCU settings. Our study showed that TPCU 
intervention significantly decreased mortality in PCU and 
hospital and PCU LOS despite the fact patients in TPCU were 
older and had higher disease severity, and ROM. Increased 
post-PCU hospital LOS and total mean direct costs inclusive 
of telemedicine costs coincided with improved survival rates. 
Evidence from our study suggests that Telemedicine decreases 
overall mortality and LOS within PCU without substantial cost 
incurrences.
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